BOS
BASEL
2022
Programme
Speakers
Attendees
Sponsors
Posters
Partnering
Location
Register
LOGIN
Login
Forgot Password
8–9 June
Basel, Switzerland
Speaker
Select...
Andrea Fetz
Andreas Herrmann
Antoine Thomas
Ben Perry
Brian Cox
Christian Arquint
Christian Lutz
Christoph Becker
Claire Wombwell
Constantin Hozsa
Firelli Alonso
Geert Van Raemdonck
Hanu Ramachandruni
Hayley Binch
Joan Herbert
John Mykytiuk
Josef Messinger
Kerstin Wilken
Marianne Spaene
Martin Bates
Mohamed Chtaini
Nicolas Lantz
Richard Lewis
Simone Steiner
Stacey Crane
Susanne Jörg
Sven Wagner
Tarita Qveflander
Thierry Schlama
Thomas Schlatterer
Ulrich Ruemenapp
Werngard Czechtizky
Xiaona Jing
Yogeshwar Bachhav
OR Category
Select...
CMC
Discovery
CMC: Small Molecules
CMC: Biologics
CMC: Biologics, Drug Substance
CMC: Biologics, Drug Product
CMC: Biologics, Analytical
CMC: Biologics, Drug Delivery
CMC: Biologics, Packaging
CMC: Small Molecules, Drug Substance
CMC: Small Molecules, Drug Product
CMC: Small Molecules, Analytical
CMC: Small Molecules, Drug Delivery
CMC: Small Molecules, Packaging
Discovery: Target Discovery
Discovery: Discovery Chemistry
Discovery: Discovery Biology
Discovery: DMPK
Speakers
Dr Andrea Fetz
Head Project Management, Solvias AG
Dr Andreas Herrmann
CEO, CORAT Therapeutics GmbH
Dr Antoine Thomas
Head of External Manufacturing, Exevir Bio BV
Dr Ben Perry
Senior Discovery Manager, Drugs for Neglected initiative (DNDi)
Prof Brian Cox
Emeritus Professor of Pharmaceutical Chemistry, B Cox Consulting Ltd
Dr Christian Arquint
Head of clinical manufacturing, T3 Pharmaceuticals AG
Dr Christian Lutz
Director Project Management CMC, Heidelberg Pharma Research GmbH
Christoph Becker
CEO and Partner, NegotiumBio GmbH
Dr Claire Wombwell
Team Leader, Cambridge
Constantin Hozsa
Project Leader Formulation / Process Development, Siegfried AG
Dr Firelli Alonso
Senior Director, External Supply (Biotherapeutics) , Pfizer
Geert Van Raemdonck
Scientist HR-MS, AnaBioTec
Dr Hanu Ramachandruni
Sr. Director, Pharmaceutical Development, Medicines for Malaria Venture (MMV)
Dr Hayley Binch
Head of Medicinal Chemistry, F. Hoffman-La Roche
Dr Joan Herbert
Senior Director, Business Development, Medicines for Malaria Venture
Dr John Mykytiuk
Solid State Manager, Sterling Pharma Solutions Ltd
Dr Josef Messinger
Head of Structural Biology and Analytics, Orion Pharma
Dr Kerstin Wilken
Key Account Manager, IDT Biologika
Ms Marianne Spaene
CBO, Siegfried AG
Mr Martin Bates
Solid Form Scientist, Johnson Matthey
Mohamed Chtaini
Exec. Director, Global Biologics Commercial MFG, Incyte Biosciences Technical Operations Sàrl
Dr Nicolas Lantz
Head of scientific committee, Swiss Sanfilippo Foundation
Dr Richard Lewis
Director, Data Science, Novartis
Dr Simone Steiner
Head Technical development and Manufacturing, Tigen Pharma
Miss Stacey Crane
Business Development Manager, Melbourn Scientific Ltd T/A Intertek Melbourn
Dr Susanne Jörg
Chief Customer Delivery Officer, Ten23 health
Sven Wagner
Chief Business Officer, SpiroChem AG
Dr Tarita Qveflander
Head of Strategic Sourcing and Direct Procurement, Swedish Orphan Biovitrum AB
Dr Thierry Schlama
Director, Biocatalysis, Novartis Pharma AG
Thomas Schlatterer
Head of Sales, CARBOGEN AMCIS AG
Dr Ulrich Ruemenapp
Head of Launch Preparation (Biological Development), Bayer Schering Pharma AG
Dr Werngard Czechtizky
Head Medicinal Chemistry, Respiratory and Immunolo, AstraZeneca
Dr Xiaona Jing
VP Global Product Development, Multitude Therapeutics
Dr Yogeshwar Bachhav
Associate Director, AiCuris Anti-infective Cures AG
